User profiles for Mihir Kakara

Mihir Kakara

University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Cited by 613

[HTML][HTML] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

SA Apostolidis, M Kakara, MM Painter, RR Goel… - Nature medicine, 2021 - nature.com
SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

…, I Mexhitaj, KR Patterson, M Kakara… - Proceedings of the …, 2023 - National Acad Sciences
A small proportion of multiple sclerosis (MS) patients develop new disease activity soon
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …

[HTML][HTML] COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from …

…, S Podury, A Prasad, S Wen, G Guthrie, M Kakara… - Journal of …, 2021 - Springer
Background The literature on neurological manifestations in COVID-19 patients has been
rapidly increasing with the pandemic. However, data on CNS inflammatory disorders in COVID…

Updates on efficacy and safety outcomes of new and emerging disease modifying therapies and stem cell therapy for Multiple Sclerosis: A review

S Peterson, A Jalil, K Beard, M Kakara… - Multiple Sclerosis and …, 2022 - Elsevier
Multiple Sclerosis (MS) is a chronic neurodegenerative autoimmune disorder of the central
nervous system (CNS) and the most common cause of serious physical disability in working-…

Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review

…, H Yu, M Elkhooly, S Jaiswal, A Jena, M Kakara… - Journal of the …, 2022 - Elsevier
Progressive multifocal leukoencephalopathy (PML) is a subacute CNS inflammatory disease
seen primarily among immunocompromised patients. It is caused by the JC virus (JCV), a …

The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis

JR Berger, M Kakara - Multiple Sclerosis and Related Disorders, 2022 - Elsevier
Multiple sclerosis is a chronic immune-mediated disease of the central nervous system that
has aspects of repetitive inflammatory activity as well as a slow neurodegenerative process. …

Anti‐CD20 monoclonal antibody therapy in postpartum women with neurological conditions

…, TW Hale, D Jacobs, M Kakara… - Annals of Clinical …, 2023 - Wiley Online Library
Objective Postpartum, patients with multiple sclerosis (MS) and neuromyelitis optica spectrum
disorder (NMOSD) have increased risk for disease activity. Anti‐CD20 IgG1 monoclonal …

[HTML][HTML] Relevance of CSF, serum and neuroimaging markers in CNS and PNS manifestation in COVID-19: a systematic review of case report and case series

S Podury, S Srivastava, E Khan, M Kakara, M Tandon… - Brain Sciences, 2021 - mdpi.com
Background: The data on neurological manifestations in COVID-19 patients has been
rapidly increasing throughout the pandemic. However, data on CNS and PNS inflammatory …

[HTML][HTML] Outcomes of status epilepticus and their predictors in the elderly—a systematic review

…, M Eshraghi, KG Akers, S Hadidchi, M Kakara… - Seizure, 2020 - Elsevier
Status epilepticus (SE) is associated with high mortality and morbidity. Although SE is frequently
seen in elderly patients, there is a lack of a cohesive report of outcome measures and …

The Bridging the Gaps Program: Three Decades of Collaborative Service-Oriented Learning in the Health Professions

M Kakara, E Martinak, B McCormick… - Academic …, 2023 - journals.lww.com
Health professions educators are continuing to develop training programs for future health
care professionals to understand social determinants of health and address practical needs of …